Vistakon Medical Device Company Intelligence Report

  • March 2011
  • -
  • Espicom Business Intelligence

Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.

Vistakon is focused on investing in innovation, building the Acuvue brand and fortifying its position as the worldwide leader in vision care. The company’s growth strategy is to capitalise on the global contact lens market’s huge potential.

Vistakon believes it has strong competitive advantages in the global contact lens market. These include its proprietary manufacturing platforms, which enable it to produce high volumes of lenses; its R&D organisation, which it believes has the highest level of investment in the industry; and the strong market recognition of its Acuvue brand.

As contact lenses are non-reimburseable medical devices, purchase decisions are influenced by the consumer and eye care professionals, so brand recognition is very important. The company therefore has a dual marketing approach for both the professional and the consumer. For professionals, the Johnson & Johnson Vision Care Institute is central to its approach. This training and education centre operates on the same principles as J&J’s Ethicon Endo-Surgery Institute and has expanded overseas to include sister institutes in 13 cities around the globe. The institute has trained more than 50,000 eye care professionals worldwide.

In addition to its current strong position, the company believes it will see continued improvements in its business performance through growth in the contact lens market due to increased demand for products and the current under-penetration of contact lenses in both the developed and developing world. In order to achieve growth in the entire global market, the company has a strategy of developing products to suit regional needs, for example, its 1•Day Acuvue Define lenses for women in the Asia Pacific region.

Vistakon believes the BRIC countries (Brazil, Russia, India and China) offer a significant opportunity for the company and it is specifically targeting the 14-44 age group. In Russia, Vistakon believes it is already the leading supplier of disposable contact lenses and was named the best contact lens manufacturer by the Moscow Optical Exhibtion in 2010. In China, where Vistakon claimed the leadership position in the top three cities in 2009 and plans an aggressive expansion into the top 20 cities, the company estimates the contact lens market will increase to US$1 billion in the next five years.

This company report provides

Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format

Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Strategic Focus
Investigates the company’s aims and its areas of focus

Products
Core product areas, key brands, product approvals and launches
Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?

Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities

Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded

Litigation

Key Corporate Events



The report was produced as part of Medical Device Companies Analysis (MDCA). For more information on MDCA, click here.

Table Of Contents


Contents

OVERVIEW.1
FINANCIAL REVIEW2
2010 Financial Results.2
STRATEGIC FOCUS4
PRODUCTS5
Soft Contact Lens Market.7
RESEARCH AND DEVELOPMENT.9
MANUFACTURING, DISTRIBUTION AND TRAINING10
AGREEMENTS.11
Allergan 11
PurePulse 11
LITIGATION.12
KEY CORPORATE EVENTS13

List of Tables

SUMMARY OPERATING RESULTS.iii
VISION CARE FRANCHISE.iii
Recent Key Events1
Vision Care - Annual Sales, 2006-2010.2
Technology Glossary6
Vistakon - Recent Selected Product Approvals, Clearances and Planned Submissions, as of January 2011
Global Soft Contact Lens Market Rankings by Geographic Area, 3Q 20107

List of Charts

Johnson and Johnson - Medical Devices and Diagnostics Segment - 2010 Sales by Major Franchise
Vision Care - Annual Sales, 2006-2010.3
Vision Care - Annual Sales by Geographic Area, 2006-2010.3
Vistakon's Share of the Global Soft Contact Lens Market, 3Q 2010.7
Global Soft Contact Lens Market - Estimated Five-Year Sales Trend by Product.8
Global Soft Contact Lens Market - Estimated Five-Year Sales Trend by Geographic Region.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Rohto Pharmaceutical Co., Ltd. (4527) - Financial and Strategic SWOT Analysis Review

Rohto Pharmaceutical Co., Ltd. (4527) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • June 2014
  • by Global Data

Summary ROHTO Pharmaceutical Co.,Ltd. (ROHTO Pharmaceutical) is a pharmaceutical company. The company manufactures and markets eye care and skin care products, cosmetics, functional foods, other internal ...

Sun Hing Vision Group Holdings Ltd. (Symbol:0125) SWOT Analysis, Strategy, Revenues and Profits

Sun Hing Vision Group Holdings Ltd. (Symbol:0125) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Eyecare Partners Limited - Financial and Strategic SWOT Analysis Review

Eyecare Partners Limited - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • June 2014
  • by Global Data

Summary This comprehensive SWOT profile of Eyecare Partners Limited provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.